Frazier Management’s Passage Bio PASG Stock Holding History

Frazier Management’s Portfolio PASG Stock Details PASG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-250,461	Closed	-$31.8M	–	19
2021 Q4	$31.8M	Hold	250,461	–	–	2.45%	15
2021 Q3	$49.9M	Hold	250,461	–	–	3.99%	9
2021 Q2	$66.3M	Hold	250,461	–	–	6.12%	3
2021 Q1	$87.6M	Hold	250,461	–	–	7.02%	3
2020 Q4	$128M	Hold	250,461	–	–	9.86%	3
2020 Q3	$65.7M	Hold	250,461	–	–	5.9%	5
2020 Q2	$137M	Hold	250,461	–	–	12.02%	3
2020 Q1	$78.9M	Buy	+250,461	New	+$78.3M	8.95%	3

Other funds holding PASG

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Frazier Management's PASG Position: Q1 2022 in Review

Frazier Management sold out of Passage Bio (PASG) in Q1 2022, closing a stake of 250,461 shares — an estimated $31.8M sold.

Frazier Management first reported a position in PASG in Q1 2020 and held it in 8 quarters. The position peaked at $137M in Q2 2020. 108 funds tracked by Wall St. Rank hold PASG as of Q1 2022.

Frazier Management reported no remaining Passage Bio position as of Q1 2022 after selling out during the quarter.
Frazier Management sold 250,461 Passage Bio shares in Q1 2022, an estimated $31.8M.
Frazier Management first reported a position in Passage Bio in Q1 2020 and held it in 8 quarters.
Frazier Management's Passage Bio position peaked at $137M in Q2 2020.
108 funds tracked by Wall St. Rank held Passage Bio as of Q1 2022.

Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.